Archives

by in
Entry Author Date Location
With Atlas Cash and Berkeley Tools, Intellia Joins the CRISPR Fray 11/18/14 Boston
New Research Could (Finally) Remove RNAi’s Commercial Limitations 11/17/14 National
Juno, Less Than a Year Old, Lines up IPO to Fund Cancer Work 11/17/14 Seattle
What Early Looks From ASH Tell Us About Cancer Immunotherapy 11/07/14 National
Proteostasis, Astellas Join up on Genetic Disease Drugs 11/04/14 Boston
East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More 10/31/14 Boston
Aiming to Boost Innovation, Trinity Fine-Tunes Its Tech Transfer 10/30/14 National
Opsona, And Pharma Backers, Await Day of Reckoning for Kidney Drug 10/29/14 National
Pharmas, Others Bet $33M More on Aileron’s P53 Peptide Drug 10/29/14 Boston
East Coast Biotech Roundup: PureTech, Celgene, Unum, Biogen & More 10/24/14 Boston
New Atlas Startup Gets “Quartet” of Backers, $17M For Pain Drugs 10/23/14 Boston
Proteon Cuts Price, Boosts Shares to Bag $61M in IPO 10/22/14 Boston
With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors 10/14/14 Boston
What Seattle Needs (Part 2): Dealing With Amgen’s Upcoming Departure 10/07/14 Seattle
Austin Biotech Savara Nets $10M to Develop Cystic Fibrosis Drug 10/06/14 Texas
East Coast Biotech Roundup: Intarcia, Atlas, Visterra, & More 10/06/14 Boston
What Seattle Needs (Part 1): “Semi-Successful” Biotech Companies 10/06/14 Seattle
ZMapp Ebola Drug Production Set for Texas, Possibly North Carolina 09/30/14 Raleigh Durham
Roundup: New A&M Center, Funds for Ortho Kinematics, Encore Vision 09/19/14 Texas
Proteon, Moving on From Ill-Fated Novartis Deal, Files IPO Pitch 09/16/14 Boston
East Coast Biotech Roundup: Maraganore, Flex, NPS, Retrophin, & More 09/15/14 Boston
An Intriguing Program Takes on Tropical Diseases—But Not Ebola 09/10/14 National
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
Merck, Leapfrogging Bristol-Myers, Wins FDA Nod for Cancer Drug 09/04/14 New York
Which Countries Excel in Creating New Drugs? It’s Complicated 09/02/14 Seattle
NJ’s Medicine Chest Thins Again as GE Health Unit Heads for MA 08/19/14 Boston
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
Novartis Helps Pour $16M Into Seventh Sense for Pain-Free Blood Tests 08/13/14 Boston
With $310M and Public Investors Aboard, Is a Juno IPO Next? 08/05/14 Seattle
G1, Out to Shield Body From Chemo, Heads to First Clinical Test 07/28/14 Raleigh Durham
Page 1 of 13 next page »